chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning an approximately 9 month old female who was vaccinated with a first, second, and third oral dose of Rotateq on 08-Jun-2006, 25-Aug-2006, and 20-Oct-2006, respectively. Concomitant vaccine included a first, second, and third dose of Pediarix administered on the same dates, respectively.  "About a week ago," on approximately 02 Feb 2007 the patient experienced rotavirus. The patient was in the emergency room but was not hospitalized. Subsequently the patient fully recovered. It was reported that the patient's father also came down with rotavirus, but did not have to be hospitalized. No product quality complaint was involved. No other information was provided. The patient's twin brother experienced rotavirus following vaccination with Rotateq. Additional information has been requested.
Initial report received on 19 December 2007 from a health care professional.  The health care professional reported this case to another manufacturer (no reference number provided), who forwarded the information to Sanofi Pasteur.  A patient (age and gender not reported) received injections of Menactra and DTaP (manufacturer unknown) on unspecified date.  The lot number and administration information was not reported for either vaccine.  An unspecified amount of time later, the patient fainted.  No other information was provided.  It was not reported whether the patient recovered from the event.
I had a cortisone injection in left hip for bursitis and was prescribed Prednisone for 6 days by Dr. After taking the Prednisone I developed lower back pain (LT SIDE) and then developed burning of the left upper thigh. The burning persisted and on 7/7/11 at 4 PM, 8 pustules appeared on my upper left thigh. Since I was scheduled to leave out of town and it was Friday, I called the Dermatologist immediately and was seen that day at 11:30 AM. Dr. diagnosed it as Shingles and I was prescribed Valacyclovir 1 gm tablets 3x/day for 10 days.
swelling, muscle pain Narrative: 57 y/o received first dose of COVID19 (Moderna) vaccine on 04/03/21. On 04/10/21, reported injection site was hard and swollen approximately 2 cm x 2 cm. Encouraged to call the team if swelling does not decrease over the next 2-3 days or if worsens.
Bleeding excessively; It was 4 days early and was the worse period she has experienced in 3 years; Extreme cramps; This is a spontaneous report from a contactable consumer (patient). This 15-year-old female (non-pregnant) patient received 1st dose of BNT162B2 (lot#EW0196) on 30May2021 11:00 AM, vaccine location=Left arm at single dose for COVID-19 immunization. Relevant medical history was Asthma. No any other vaccines within 4 weeks prior to the COVID vaccine. Patient received within 2 weeks of vaccination included salbutamol (ALBUTEROL), paracetamol (TYLENOL) as needed. It was 4 days early and was the worse period she has experienced in 3 years. She was bleeding excessively and extreme cramps on 02Jun2021. We thought maybe it was a coincidence. She is only 15 yrs old and has had her period for 3 years and has never experienced anything like what she has in the last month. She is due for her next period on 29Jun2021 and I pray it was not as bad as last month after the shot. Outcome of reaction/event at the time of last observation was unknown. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow up attempts needed. No further information is expected.
Feel a little achy; Chills; Headache; A spontaneous report  was received from a male patient who was administered Moderna's COVID-19 vaccine (mRNA-1273) and developed pain, chills, and headache.  The patient's medical history and concomitant medications were not reported.   On 30-DEC-2020, six days prior to the onset of the events, the patient received his first of two planned doses of mRNA-1273 (batch number: 011L20A) intramuscularly in the left arm for the prophylaxis of COVID-19 infection.   On 04-JAN-2021, the patient developed chills, headache, and felt a little achy which lasted for one day. Treatment included paracetamol.   Action taken with mRNA-1273 in response to the events was not reported.   The outcomes of the events, pain, chills, and headache, were resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt presented today 4/13/21 with mom.  When mom & Pt checked in patients name DOB verified.  Mom stated DOB 11/14/2005.  Original Appt had been scheduled with 11/14/2004.  Mom stated year was an error.  When reception changed date it stated pt was 15 and not eligible.  I was called to speak with mom and patient.  Mom stated husband brought pt and scheduled appt.  She said she knew Pfizer was for 16 and older however the system let her book and she has asthma.   I told pt she would need to wait until the pt turned 16 y/o or if Pfizer was approved for a younger age.  She  verbalized understanding and agreed.
#5 DTaP. #2 MMR, #4 IPV administered- child began itching and began to develop urticaria within 1 minute after the last immunization- epi & Benadryl adminstered per ER protocol child went to ER in ambulance.
1/11/00, awoke @ 3:00 a.m. Temp of 103, lethargic, pale, comiting, PM increased lethargy, seizure activity transferred to hospital via ambulance.  Tx IV fluids, childrens motrin
Patient refers approximately 3 hours after administrating first dose of Pfizer, started to experience stomach pain, leg weakness, and headache. Symptoms lasted approximately 36 hours. Patient refers Thursday the 9th she fainted at 5am while bathing, after the faint she had a headache
pt. recvd 1st dose hepatitis B vac & developed sore throat, lymphadenopathy, & fever.
Pt in office with twin sib gave two VARIVAX instead of one PENTACEL and one VARIVAX which was due to each pt.
Case number PHEH2013US016731 is an initial spontaneous report received from a nurse on 06 Aug 2013. This report refers to a 23-years-old female patient. Her medical history included allergy to penicillin. Her concomitant medications were not reported. She was vaccinated with three doses of RABAVERT (batch number: 473011C) at a dose of 1 ml intramuscularly on 07 Sep 2011, 14 Sep 2011 and 05 Oct 2011 respectively. The first dose was administered on left deltoid and the second and third doses were given on right deltoid. It was reported that on 15 May 2013, she had equivocal rabies titer and that the level was insufficient. She required a rabies booster. The reporter assessed the event as medically significant. The outcome of the event was not reported. No further information was provided.
No additioal AE's; A medical assistant reported that a dose of MMR II vaccine that was stored imptoperly pursuant tot temperature excursion was administered to a patient.  No additioal AE's and no PQC's were reported.; This spontaneous report has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions, and allergies were not provided.   On 22-NOV-2022, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin) (M-M-R II) subcutaneous injection, as prevention of measles, mumps and rubella infection (lot number U039910 has been verified to be valid; expiration date reported and established as 16-DEC-2023) (strength, dose, frequency, vaccination scheme, route of administration, and anatomical location were not provided). No adverse event was reported.
Patient got the FLUZONE HD vaccine on 10/1/18. She reported to her Dr. on 10/4/18 with a large area of her left arm red and with swelling. Her Dr. diagnosed the area as cellulitis and gave her a prescription for cephalexin. He informed the patient that if she did not notice the area getting better, she should report to the hospital ER in the next couple of days.
A pharmacist reported that a male received Tetanus toxoid adsorbed, purogenated in 1961 and subsequently, had an unspecified reaction 40 years ago. As of the date of this report, no further info was available.
Patient Passed out multiple times became sweaty hot and unresponsive. Lasted for 4-5 minutes before patient recovered.
Within 5mins of shot numbness in both hand and both feet.  With minutes she couldn't breath. B/P 180/97.  Took Allergy meds and they sent her to urgent care same day.  At 7pm face was swollen. She took a pill and went to bed. Now feels nausea, loss of appetite for a week.
double vision after the second dose of the Pfizer covid vaccine; This is a spontaneous report from a contactable pharmacist. A 37-year-old female patient received second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot Number: ER8730; Expiration Date: Jul2021) via an unspecified route of administration, administered in arm left on 28Apr2021 13:18 (at the age of 37-year-old) at dose 2, 0.3 ml single for covid-19 immunisation. Medical history included high blood pressure (He clarifies that on the patients profile he sees the patient is on blood pressure medication). Confirms she has the patient's paper only has high blood pressure and she doesn't see any other conditions on there. Concomitant medications were not reported. Patient did not have prior vaccinations within 4 weeks. Patient previously received first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot Number: ER8730; Expiration Date: Jul2021, via an unspecified route of administration on 31Mar2021 (at the age of 37-year-old) at dose 1, single for covid-19 immunisation. On an unspecified date in Apr2021 the patient experienced double vision after the second dose of the Pfizer covid vaccine. Reporter stated they have a 37-year-old female patient who reported of double vision after the second dose of the Pfizer covid vaccine yesterday. caller wanted to know about any reports of it. Reporter stated he is a pharmacist calling from . He has a customer who got the second dose yesterday and the customer called back saying she has double vision. Caller is wondering if there any reports on that. Reporter states he tried to check on the website, clarified as the CDC website, but did not see that. Reporter asks are there on any reports on double vision. Outcome of the event was unknown.   No follow-up attempts are needed. No further information is expected.
Per parent: child and parent were informed at check in for clinic that both Janssen and Pfizer vaccines were available. Child was excited to hear that she could have a one dose vaccine and mother was unaware that Janssen was not licensed for people under 18. Nurse providing vaccine did not recognize child's age after child and parent said they would take Janssen. Second nurse at clinic overheard part of conversation and asked providing nurse (after child had received a vaccine) if that child was 18. Providing nurse was then reminded that Janssen is not approved for people under 18. Pediatrician was consulted 2 days after event by parent. Parent was also contacted by myself and informed that there is no information currently available about any different types of expected side effects just because of age. Parent also informed that child did not need to have any other vaccine in addition to this one. Parent expressed understanding.
I just had a pain from left side neck to elbow at next day but it was gone on Sunday; I just had a pain from left side neck to elbow at next day but it was gone on Sunday; I felt little sleepy the day I got vaccine; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), via an unspecified route of administration on 18Dec2020 14:00 at a single dose on left arm for COVID-19 immunization. Medical history included hypothyroidism (Hx of hypothyroidism. Not now). No known allergies. There were no concomitant medications. For the first dose, the patient experienced, "I just had a pain from left side neck to elbow at next day but it was gone on Sunday" on 19Dec2020. The patient also reported, "I felt little sleepy the day I got vaccine" on 18Dec2020. No treatment received for the events. The outcome of the events "I just had a pain from left side neck to elbow at next day but it was gone on Sunday" was recovered on 20Dec2020 while for, "I felt little sleepy the day I got vaccine" was unknown. The patient was not pregnant. Facility type vaccine was Hospital. No other vaccine in four weeks. Not diagnosed with COVID prior vaccination. Not COVID tested post vaccination.
I developed a raised, red, rash-like skin reaction around the injection site  approximately 10 days after my first dose of the Moderna COVID19 vaccine. The  diameter of the rash expanded significantly as time went on, beginning as a fairly sizeable but tight and contained circle then transforming into a ring-like, more narrow halo. The rash was painful when pressure was applied to the site and caused great discomfort.
This spontaneous report as received from a registered nurse refers to a 4 weeks and 2 days old female infant. The pertinent medical history and concomitant medications were not reported. On 17-MAR-2015, the patient was vaccinated with ROTATEQ dose 1, 2 ml, oral. No adverse event was reported. Additional information has been requested.
I am still getting pain at the injection site; Retricted arm movement at the injection site; This case was reported by a consumer and described the occurrence of injection site pain in a 85-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had an occurrence of shingles 56 years ago).   On 28th July 2021, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced injection site pain and injected limb mobility decreased. On an unknown date, the outcome of the injection site pain and injected limb mobility decreased were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain and injected limb mobility decreased to be related to Shingrix.  Additional details provided were as follows: The case was reported by patient himself/herself. Age at vaccination was not reported. The patient received a dose of Shingrix and till the time of reporting, patient still getting pain and restricted arm movement at the injection site. The patient asked how long is the pain going to persist because he/she was reluctant to get the second injection. The patient stated that he/she was good in health. The patient had an occurrence of shingles in the exactly 56 years ago, possibly originated from contact with someone who had Chicken Pox at the wedding reception and did not know if that still affects the immunity. The patient asked for some advice and if he/she need to persue further medical advice. The reporter consented to follow-up.
Headache Fever/Chills  Ringing in ears Loss of balance Visual distortion  Nausea/gas Sharp stomach pain comes and goes Injection site soreness  Gout flare up Cough/congestion  Shortness of breath requiring oxygen  Symptoms didn?t improve much for about 7 days
My son developed a serious rash on his body after receiving the first shot of GARDASIL, red, raised bumps, ranging in size.
1 day after Tdap - Headache, nausea, leg/thigh pain, night sweats.
Monovalent Pfizer was given in error instead of the Bivalent Pfizer
Client received Pfizer booster injection at 3:40 PM and was asked to wait in waiting room, At 3:45 PM, client had c/o of being lightheaded and dizzy. Band aid called v/s take, client remained alert and oriented, skin warm and dry. Client denies CP, tingling and SOB.  Pulse ox 94% on RA. Mom came in from parking lot to be with client. Mom states client has been in ER 03/09/2022 due to migraines, new medication started Ubrelvy. Mom called neurologist and ARNP spoke with neurologist via phone. Client was given water and cool cloth placed on head. After about 20 minutes, client symptoms improved. ARNP informed client and Mom if symptoms worsen to go to ER for evaluation. Client able to walk independently without any assistance, left with Mom @ 4:10 PM
After administration, employee stated feeling dizzy; place head btw knees; continued feeling dizzy; place employee lying on floor on side and attempted to give OJ - blood sugar 80; no LOC; called rapid response; vitals and EKG WNL; transported to ED via gurney; seen by ED MD; D/C home.
cellulitis of rt arm, approx 20cm x 10cm around inj site;severe itching/head from erythematous area;pt noticed first signs of itching w/small area of redness/rash;allergic rxn;
stinging in his feet and hands; heated by moving too fast or walking to fast; rash on his neck, his upper chest,and both arms.; Greater than 35 days between Covid-19 doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (stinging in his feet and hands), MILIARIA (heated by moving too fast or walking to fast), RASH (rash on his neck, his upper chest,and both arms.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between Covid-19 doses) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (stinging in his feet and hands), MILIARIA (heated by moving too fast or walking to fast), RASH (rash on his neck, his upper chest,and both arms.) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between Covid-19 doses). At the time of the report, PAIN (stinging in his feet and hands), MILIARIA (heated by moving too fast or walking to fast) and RASH (rash on his neck, his upper chest,and both arms.) outcome was unknown and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Greater than 35 days between Covid-19 doses) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant product information was not provided.  The dermatologist told him to get an anti-itch cream which helps to cool him. His dermatologist also said there was nothing in the Moderna vaccine that cause an allergic reaction nor does not have allergies. However, his immune system is overworked, and making too many antibodies. Patient restated the dermatologist told him the proteins in his body was causing him to develop antibodies. Patient stated he does not plan to obtain the 2nd vaccine.   This case was linked to MOD-2021-270627, MOD-2021-229942 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: First dose information was updated, new events were  added.
Peripheral poly-sensory neuropathy involving bilateral lower extremities.  Symptoms include numbness, tingling, burning, and pain in bilateral feet.  Signs included loss of sensation to light touch, pin-prick, hot & cold, involving the peripheral lower extremities.  Onset was gradual, starting one week after my second Moderna COVID-19 vaccination, and symptoms progressively worsened over time.
After receiving the vaccine I had pain at the injection site. I had a sore arm for about 2 days. On April 23, 2022 on a Saturday night I developed a dry scratchy throat. That lasted through Sunday. The symptoms were mild. Then on Monday April 25, 2022 I had a headache, body aches, a cough, sore throat, tired, and a runny nose. I took an at home rapid COVID-19 test, but the results were unclear. Over the next five days I had a fever, body aches, congestion, and a  sore throat. Earlier on I was also having a little bit of trouble breathing. I called my doctor and he prescribed me an inhaler and coughing pills. After about 5 days I started to feel better, but then I lost my sense of smell. Yesterday my smell has started to come back. I am still a bit congested with a runny nose, cough, and a little bit of brain fog.
lt arm swelling shoulder to elbow, redness, hard, warm to touch, c/o pain;
This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history includes penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, at 21:00, 12 hours after injection, the patient experienced chills, joint pain and general discomfort. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of event. The clinical outcome of the events chills, joint pains and general discomfort was recovered on an unknown date at the time of this report. No follow-up attempts are needed. No further information is expected.
I95.9 HYPOTENSION 1/9/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/9/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE R09.02 HYPOXIA 1/9/2022 ATRIAL FIBRILLATION W RAPID VENTRICULAR RESPONSE I95.9 HYPOTENSION 1/9/2022 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/9/2022 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION R09.02 HYPOXIA 1/9/2022 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION
severe Headache; Fever; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe Headache), PYREXIA (Fever) and MYALGIA (Body ache) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (severe Headache), PYREXIA (Fever) and MYALGIA (Body ache). At the time of the report, HEADACHE (severe Headache), PYREXIA (Fever) and MYALGIA (Body ache) had resolved.            The  concomitant medications on use were not provided. No laboratory data was provided. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.
25 minutes after vaccination patient developed red rash on left side of face and neck it then spread to right side of face and neck and chest and then forehead.   She was evaluated by County EMS, given 50 mg Benedryl orally at 12:20pm by county nurse and transported via ambulance to the hospital at 12:25pm.
The day after the shot i felt very fatigued, headache. Two days after the shot I had chest pain, heart palpitations, and nausea.   Three days after the vaccine i had chest pain, heart palpitations and went to the ER.  They did EKG, chest x ray, and blood work.  Screening came back clear, however symptoms remain. Following up with a cardiologist.